NR566 ACTUAL EXAM SCRIPT 2026 FULL
QUESTIONS AND CORRECT ANSWERS
◉ Triptans MOA.
Answer: constrict intracranial blood vessels and suppress release of
inflammatory neuropeptides
◉ Sumatriptan contraindications.
Answer: contraindicated in pts with hx of ischemic HD, MI,
uncontrolled HTN or other heart dz. Avoid in pregnancy
◉ Ergot Alkaloids and dihydroergotamine.
Answer: 2nd line therapy after 1st doesnt work
◉ Pramipexole can cause.
Answer: sleep attacks (overwhelming and irresistible sleepiness)
◉ screening before pramipexol prescribing.
Answer: compulsive behaviors
◉ Parkinsons disease.
, Answer: underlying cause of motor symptoms is loss of
dopaminergic neurons in the substantia nigra
◉ cardinal symptoms PD.
Answer: resting tremor, rigidity, postural instability, slowed
movement
◉ Levodopa.
Answer: most effective med for Parkinsons
◉ Additions to levodopa.
Answer: dopamine agonists, MAOB inhibitors, COMT inhibitors,
Amantadine and anticholinergics
◉ Amantadine (symmetrel).
Answer: NMDA receptor antagonist. Effective as monotherapy and
adjunct therapy for off times and dyskinesia
◉ Gocovir.
Answer: extended release amantadine. Used for dyskinesias
◉ Benztropine (Cogentin).
QUESTIONS AND CORRECT ANSWERS
◉ Triptans MOA.
Answer: constrict intracranial blood vessels and suppress release of
inflammatory neuropeptides
◉ Sumatriptan contraindications.
Answer: contraindicated in pts with hx of ischemic HD, MI,
uncontrolled HTN or other heart dz. Avoid in pregnancy
◉ Ergot Alkaloids and dihydroergotamine.
Answer: 2nd line therapy after 1st doesnt work
◉ Pramipexole can cause.
Answer: sleep attacks (overwhelming and irresistible sleepiness)
◉ screening before pramipexol prescribing.
Answer: compulsive behaviors
◉ Parkinsons disease.
, Answer: underlying cause of motor symptoms is loss of
dopaminergic neurons in the substantia nigra
◉ cardinal symptoms PD.
Answer: resting tremor, rigidity, postural instability, slowed
movement
◉ Levodopa.
Answer: most effective med for Parkinsons
◉ Additions to levodopa.
Answer: dopamine agonists, MAOB inhibitors, COMT inhibitors,
Amantadine and anticholinergics
◉ Amantadine (symmetrel).
Answer: NMDA receptor antagonist. Effective as monotherapy and
adjunct therapy for off times and dyskinesia
◉ Gocovir.
Answer: extended release amantadine. Used for dyskinesias
◉ Benztropine (Cogentin).